Avalign Technologies Inc.

A contract manufacturer of medical devices is on non-accrual for a second quarter in a row and its debt value decreasing while awaiting. a promised restructuring that's likely to involve its 3 BDC lenders. A "debt-for-equity swap" seems likely.